ESMO 20th World Congress on Gastrointestinal Cancer

C Concurrent Session 1 N Concurrent Session 2 T Concurrent Session 3 O Concurrent Session 4 D Debate

K Keynote Lecture R Reception S Sessions Y Symposia

JUNE 20 • WEDNESDAY

 13:30 – 14:30 Y Lunch Symposia TBA

 14:45 – 16:00 S Session I: Welcome, Selected Abstracts, and Opening Lecture Auditorium A
Session Chair: Eric VanCutsem, Mario Dicato, Josep Tabernero

 14:46 – 14:50 S Welcome and introduction Auditorium A

Faculty: Mario Dicato, Josep Tabernero, Eric VanCutsem

 14:50 – 15:30 S Presentation of selected abstracts Auditorium A

 15:30 – 16:00 S Opening Lecture: The microbiome in colon cancer Auditorium A

Faculty: Herbert Tilg

 16:00 – 18:30 S Session II: Cancer of the Pancreas and Biliary Tract Auditorium A
Session Chair: Teresa Macarulla

 16:01 – 16:20 S Genetics in pancreatic cancer: Implications for clinical practice Auditorium A
Faculty: Zsofia K. Stadler

 16:20 – 16:40 S Are we making progress in surgery of the pancreas? Auditorium A

Faculty: Baki Topal

 16:40 – 17:00 D Is adjuvant or neo-adjuvant treatment for resectable pancreatic cancer the way to go? Auditorium A
Faculty: Jordan D. Berlin, Pascal Hammel

 17:00 – 17:20 D Adjuvant treatment of pancreatic cancer Auditorium A

Faculty: Thierry Conroy, Jean-Luc Van Laethem

 17:20 – 17:50 S Presentation of selected abstracts Auditorium A

 17:50 – 18:10 S Improving the outcome of patients with metastatic pancreatic cancer Auditorium A
Faculty: Philip A. Philip

 18:10 – 18:30 S New agents/strategies on the horizon in bile duct cancer Auditorium A
Faculty: Michel Ducreux

 19:20 – 20:50 Y Evening Symposia TBA

C Concurrent Session 1 N Concurrent Session 2 T Concurrent Session 3 O Concurrent Session 4 D Debate

K Keynote Lecture R Reception S Sessions Y Symposia

JUNE 21 • THURSDAY

 08:00 – 08:50 C Session III: Meet the Expert Concurrent Presentations Level II

 08:00 – 09:30 N Session IV: Presentation of Selected Abstracts on Non-Colorectal Cancer Auditorium B
Session Chair: Erika Martinelli

 08:00 – 09:35 T Session V: Interpreting Clinical Trials Results Auditorium A

Session Chair: Axel Grothey, Rachel Riechelmann

 08:01 – 08:20 T Evaluating predictive markers and subgroups in clinical trials: Caution and best practices
Faculty: Lindsay Renfro Auditorium A

 08:01 – 08:50 C Advances in surgery of rectal cancer: Workshop Level II

Faculty: Andre D'Hoore, Rodrigo Perez

 08:01 – 08:50 C Carcinoma of unknown origin Level II

Faculty: George Pentheroudakis

 08:01 – 08:50 C New endoscopic screening tools: NBI, chromoendoscopy: How do they help us? Level II
Faculty: Nadir Arber, Jaroslaw Regula

 08:01 – 08:50 C Teaching on new evolutions in radiation oncology Level II

Faculty: Karin Haustermans, Vincenzo Valentini

 08:01 – 09:10 N Presentations of selected abstracts Auditorium B

 08:20 – 08:40 T Clinical interpretation and validity of clinical trials: When do they become practice changing?
Faculty: Alberto Sobrero Auditorium A

 08:40 – 09:20 T What to use and to improve the evaluation of responses Auditorium A
Faculty: Christoph Deroose, Raquel Perez-Lopez

 08:50 – 09:30 N Presentation of selected abstracts Auditorium B

 09:10 – 09:25 N Highlights of posters at ESMO GI on non-CRC Auditorium B

 09:20 – 09:30 T Panel discussion Auditorium A

 09:30 – 11:25 S Session VI: Esophageal and Gastric Cancers Auditorium A

Faculty: Michel Ducreux, Kei Muro

 09:31 – 09:50 D Management of squamous cell cancer for the esophagus Auditorium A
Faculty: David H. Ilson, Florian Lordick

 09:50 – 10:10 D Locally advanced GE junction cancer Auditorium A

Faculty: David Cunningham, David H. Ilson

 10:10 – 10:30 S Is FLOT the only standard in the perioperative setting? Auditorium A

 10:30 – 11:00 K Keynote Lecture: Progress in unraveling the molecular taxonomy in oesophageal and gastric
cancer Auditorium A
Faculty: Patrick Tan

 11:00 – 11:30 Break and poster viewing Auditorium A

 11:00 – 11:30 Poster discussion guided tours Exhibition Hall

 11:30 – 13:10 S Session VII: Gastric Cancer Auditorium A
Session Chair: David Cunningham

 11:31 – 12:00 K Keynote Lecture: Hereditary aspects of gastric cancer Auditorium A

Faculty: Fatima Carneiro

 12:00 – 12:30 S Presentation of selected abstracts Auditorium A

 12:30 – 12:50 S Metastatic gastric cancer: Where are we with check-point inhibitors in gastric cancer? Auditorium A
Faculty: Kei Muro

 12:50 – 13:10 S Metastatic gastric cancer: New targeted agents in metastatic gastric cancer Auditorium A
Faculty: Yelena Janjigian

 13:10 – 15:10 Lunch Auditorium A

 13:25 – 14:55 Y Lunch Symposia TBA

 15:10 – 16:40 S Session VIII: Diseases and Cancers of the Liver Auditorium A
Session Chair: Thomas Seufferlein, Chris Verslype

 15:11 – 15:40 K Keynote Lecture: Progress in liver transplantation in GI malignancies: HCC, biliary tract, NET, colon
Auditorium A

 15:40 – 16:10 S Tumor board on HCC Auditorium A

Session Chair: Chris Verslype
Faculty: Ghassan Abou-Alfa, Jordan D. Berlin, Christoph Deroose, Thomas Seufferlein

 16:10 – 16:20 S Presentation of selected abstract Auditorium A

 16:20 – 16:40 S How to integrate new agents in HCC Auditorium A

Faculty: Ghassan Abou-Alfa

 16:40 – 17:10 Break and poster viewing Exhibition Hall

 17:10 – 19:00 S Session IX: Expert Highlights: What is new in this disease? Auditorium A
Session Chair: Nadir Arber, Mario Dicato

 17:11 – 17:30 S What is new in NET in the last 12 months? Auditorium A

Faculty: Marianne Pavel

 17:30 – 17:50 S What is new in GIST in the last 12 months? Auditorium A

Faculty: John Zalcberg

 17:50 – 18:10 S What is new in anal cancer in the last 12 months? Auditorium A
Faculty: Michel Ducreux

 18:10 – 18:30 S What is new in bile duct cancer in the last 12 months? Auditorium A
Faculty: Juan W. Valle

 18:30 – 19:00 K Keynote Lecture: Next generation eco-friendly specific antibiotics with reduced resistance
Faculty: Ada Yonath Auditorium A

 19:20 – 20:50 Y Evening Symposia TBA

 19:30 – 21:00 R 20th Anniversary Celebration Reception TBA

C Concurrent Session 1 N Concurrent Session 2 T Concurrent Session 3 O Concurrent Session 4 D Debate

K Keynote Lecture R Reception S Sessions Y Symposia

JUNE 22 • FRIDAY

 08:00 – 09:20 C Session X: Case Discussion on Liver Metastases Level II

 08:00 – 09:20 N Session XI: Presentation of Selected Abstracts: Colorectal Cancer Auditorium B

 08:00 – 09:20 T Session XII: ESMO Session: Focus on Young Medical Oncologists Level II
Session Chair: Josep Tabernero, Guillem Argiles

 08:00 – 09:20 O Session XIII: Prevention and Screening of Colon Cancer Level II
Session Chair: Nadir Arber, Jaroslaw Regula

 08:01 – 08:10 O Presentation of selected abstract Level II

 08:01 – 08:20 T Role of Fusobacterium Nucleatum and intestinal microbiota in CRC pathogenesis and evolution
Faculty: Paolo G. Nuciforo Level II

 08:01 – 08:40 N Presentation of selected abstracts Auditorium B

Faculty: Roberto Labianca

 08:01 – 09:20 C Locoregional treatment for liver metastases: How to choose within the toolbox and when to go for
locoregional treatments Level II
Session Chair: Bernard Nordlinger
Faculty: Peter Gibbs, Thomas Gruenberger, Karin Haustermans

 08:10 – 08:30 O Genetic testing for familial and hereditary colorectal cancer Level II
Faculty: Zsofia K. Stadler

 08:20 – 08:40 T Drugging TGF-beta pathway as a way to foster immune responses in mCRC Level II

 08:30 – 08:50 O Screening for colon cancer: What has been achieved in 2018 and new prospects Level II
Faculty: Jaroslaw Regula

 08:40 – 09:00 T The importance of having a mentor in the European oncology environment Level II

 08:40 – 09:10 N Presentation of selected abstracts Auditorium B

 08:50 – 09:10 O Will chemoprevention become a reality? Level II

Faculty: Nadir Arber

 09:00 – 09:20 T How to find a good mentor in Europe Level II

Faculty: Erika Martinelli

 09:10 – 09:20 N Highlights of Posters at ESMO GI on colorectal cancer Auditorium B

 09:10 – 10:25 S Session XIV: Highlights Auditorium A

Session Chair: Mario Dicato, Eric VanCutsem

 09:11 – 09:40 K Keynote Lecture: The microbiome in colon cancer Auditorium A

Faculty: Pierre Coulie

 09:40 – 10:10 K Keynote Lecture: Coping with escalating healthcare costs in 2018 and beyond Auditorium A
Faculty: Josep Tabernero

 10:10 – 10:15 S Travel Grant Award Ceremony Auditorium A

 10:15 – 10:45 Break and poster viewing Auditorium A

 10:15 – 10:45 Poster discussion guided tours Auditorium A
Faculty: Gerald Prager, Thomas Seufferlein

 10:45 – 12:45 S Session XV: Multimodality Therapy for Rectal Cancer Auditorium A
Session Chair: Regina Beets-Tan, Karin Haustermans

 10:46 – 11:15 K Keynote Lecture: TME surgery as seen by the creator Auditorium A
Faculty: Bill Heald

 11:15 – 11:45 D Debate to be determined Auditorium A

Faculty: Regina Beets-Tan, Karin Haustermans

 11:45 – 12:15 D Rectal cancer after neoadjuvant therapy with complete clinical response Auditorium A
Faculty: Rodrigo Perez, Eric Rullier

 12:15 – 12:35 S Evolution and innovations in rectal cancer surgery Auditorium A

Faculty: Andre D'Hoore

 12:35 – 12:45 S Presentation of selected abstract Auditorium A

 12:45 – 14:45 Lunch Auditorium A

 13:00 – 14:30 Y Lunch Symposia TBA

 14:45 – 16:45 S Session XVI: Molecular Biology in CRC Auditorium A

Session Chair: Fortunato Ciardiello

 14:46 – 15:05 S How to approach the patient with a BRAF mutant tumor Auditorium A
Faculty: Chloe Atreya

 15:05 – 15:25 S Current status and perspectives on liquid biopsies in GI cancer Auditorium A
Faculty: Fortunato Ciardiello

 15:25 – 15:45 S Is circulating DNA relevant in stage II colon cancer? Auditorium A

Faculty: Peter Gibbs

 15:45 – 16:05 S New insights on the molecular and immunologic classifications in CRC 8 Auditorium A
Faculty: Sabine Tejpar

 16:05 – 16:35 D Is broad NGS testing useful in patients with metastatic colorectal cancer? Auditorium A
Faculty: Rodrigo Dienstmann, Howard Hochster

 16:35 – 16:45 S Presentation of selected abstract Auditorium A

 16:45 – 17:15 Break and poster viewing Auditorium A

 17:15 – 17:35 S Presentation of selected abstracts Auditorium A

 17:15 – 18:15 S Session XVII: Immune Mechanisms and Immune Therapy in GI Cancer Auditorium A
Session Chair: Ali Shamsheddine, Alberto Sobrero

 17:35 – 17:55 S How to increase immunogenicity in MSS CRC Auditorium A

Faculty: Guillem Argiles

 17:55 – 18:15 S Are we making progress with Immuno-Oncologic in pancreatic cancer? Auditorium A
Faculty: Eileen O'Reilly

 18:15 – 19:00 S Session XVIII: Impact of New Evolutions in GI Oncology in Emerging Regions Auditorium A

 18:16 – 19:00 D What do the new evolutions in GI cancer mean for my practice? Auditorium A
Faculty: Jorge Gallardo, Ali Shamsheddine
C Concurrent Session 1 N Concurrent Session 2 T Concurrent Session 3 O Concurrent Session 4 D Debate

K Keynote Lecture R Reception S Sessions Y Symposia

JUNE 23 • SATURDAY

 08:30 – 09:30 D How can we deal with the explosion of new treatments Auditorium A
Faculty: Steven Lemery

 08:30 – 09:30 S Session XIX: Colorectal Cancer: How to Deal with New Treatments Auditorium A
Session Chair: Alberto Sobrero, Josep Tabernero

 09:30 – 10:10 S Presentation of selected abstracts Auditorium A

Faculty: David Cunningham

 09:30 – 12:50 S Session XX: Colorectal Cancer Auditorium A

Session Chair: Josep Tabernero, Eric VanCutsem

 10:10 – 10:30 S Talk to be determined Auditorium A

 10:30 – 10:50 S The left versus right colon cancer story: What is the truth? Auditorium A
Faculty: Volker Heinemann

 10:50 – 11:20 S Break Auditorium A

 11:20 – 11:40 S How to improve on the outcome in RAS mutant tumors Auditorium A
Faculty: Heinz-Josef Lenz

 11:40 – 12:20 S Presentation of selected abstracts Auditorium A

 12:20 – 12:40 S Can we refine the selection for adjuvant treatment in stage II colon cancer? Auditorium A
Faculty: Axel Grothey

 12:40 – 12:50 S Presentation of selected abstract Auditorium A

 12:50 – 13:10 S Can we refine the selection for adjuvant treatment in stage III colon cancer? Auditorium A
Faculty: Thierry Andre

 13:10 – 15:10 Lunch Auditorium A

 13:25 – 14:55 Y Lunch Symposia TBA

 15:10 – 15:40 K Celebration Lecture: The history of GI cancer: What has been achieved over the last 20 years?
Faculty: Aimery DeGramont Auditorium A

 15:10 – 16:40 S Session XXI: From 1999 to 2018 and Beyond Auditorium A
Session Chair: Mario Dicato, Bernard Nordlinger

 15:40 – 16:10 S Multidisciplinary tumor board on resectable and borderline/potentially resectable liver metastases
Session Chair: Eric VanCutsem Auditorium A
Faculty: Axel Grothey, Erika Martinelli, Bernard Nordlinger

 16:03 – 17:10 S Session XXII: Report on Expert Consensus Discussion: The Strategy in Synchronous
Oligometastatic Colorectal Cancer Auditorium A

 16:10 – 16:40 S Molecular and hereditary tumor board Auditorium A

Session Chair: Eric VanCutsem
Faculty: Heinz-Josef Lenz, Brigetta Ma

 16:30 – 17:10 S Presentation of outcome of expert consensus discussion Auditorium A

Faculty: Mario Dicato, Josep Tabernero, Eric VanCutsem